MedTrace Logo

Efficacy of TECAR Therapy on Patient With Mechanical Neck Pain

NCT07596953 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-05-22

No results posted yet for this study

Summary

The goal of this clinical trial is to evaluate the effectiveness of TECAR therapy in improving pain intensity, cervical range of motion, and functional disability in individuals with mechanical neck pain. It will also assess whether TECAR therapy provides additional clinical benefits compared with conventional physical therapy treatment. The main questions it aims to answer are:

* Does TECAR therapy reduce pain intensity in patients with mechanical neck pain?
* Does TECAR therapy improve cervical range of motion (CROM)?
* Does TECAR therapy reduce functional disability as measured by the Neck Disability Index (NDI)? Researchers will compare participants receiving TECAR therapy combined with conventional physical therapy to participants receiving conventional physical therapy alone to determine the effectiveness of TECAR therapy in managing mechanical neck pain.

Participants will:

* Attend scheduled treatment sessions during the study period
* Receive either TECAR therapy with conventional physical therapy or conventional physical therapy alone
* Undergo assessment of pain intensity, cervical range of motion, and neck disability before and after treatment

Conditions

  • MECHANICAL BACK PAIN

Interventions

DEVICE

TECAR

Participants in the TECAR group received TECAR therapy in capacitive and resistive modes targeting superficial and deep tissues of the affected area. Each session lasted 20-30 minutes, with intensity adjusted to produce a comfortable thermal effect without pain. TECAR therapy was applied three times/week for 12 weeks, alongside a standardized exercise program identical to the control group.

OTHER

Conventional

Participants in the control group received a standardized therapeutic exercise program. The program included stretching, strengthening, and functional exercises targeting the affected region. Each session lasted 20-30 minutes and was performed three times/week for 12 weeks.

Sponsors & Collaborators

  • Saudi German Hospital

    collaborator UNKNOWN

  • Batterjee Medical College

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-07
Primary Completion
2026-09-15
Completion
2026-10-10

Countries

  • Saudi Arabia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07596953 on ClinicalTrials.gov